Zydus Lifesciences informs about press release

01 Dec 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated December 1, 2022, titled ‘Zydus receives final approval from the USFDA for Topiramate Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.



Zydus Lifesciences Share Price

892.00 10.05 (1.14%)
27-Jan-2026 10:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.40
Dr. Reddys Lab 1241.25
Cipla 1302.10
Zydus Lifesciences 892.00
Lupin 2147.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×